Skip to main content
NCBI home page
The American Journal of Pathology logoLink to The American Journal of Pathology
. 1997 Jan;150(1):25–30.

Localization of the cell proliferation and apoptosis-associated CAS protein in lymphoid neoplasms.

A Wellmann 1, L Krenacs 1, T Fest 1, U Scherf 1, I Pastan 1, M Raffeld 1, U Brinkmann 1
PMCID: PMC1858504  PMID: 9006318

Abstract

We have evaluated the expression and distribution of the cellular apoptosis susceptibility (CAS) protein in normal lymphoid tissue and malignant lymphomas. CAS protein, the product of the CAS gene, is associated with microtubules and the mitotic spindle. Immunohistochemistry with an antibody to CAS shows many CAS-positive cells in normal tonsils. The majority of strongly CAS-positive cells were localized to the dark zone of the follicles, whereas the mantle zone and interfollicular areas were essentially negative. Double staining for CAS and Ki-67 revealed co-expression of the two proliferation markers in approximately 85 to 90% of the CAS-positive cells. Different subtypes of lymphomas exhibited varying patterns of CAS expression. Low-grade non-Hodgkin's lymphoma generally revealed weak staining with CAS, with 10 to 60% of all cells being positive. In contrast, highly malignant non-Hodgkin's lymphoma and malignant cells of Hodgkin's disease displayed very strong CAS positivity, with staining of up to 80% of the atypical cells. Overall, the staining pattern of CAS and Ki-67 was superimposable within a particular lymphoma subtype. However, in all lymphomas we observed a significant fraction of CAS-positive normal and malignant lymphocytes that were Ki-67 negative, probably because they were momentarily noncycling cells. We conclude that a high expression of CAS correlates with proliferation of normal and malignant lymphoid cells. The fact that detection of CAS protein identifies a higher portion of proliferating and malignant cells than Ki-67 warrants further evaluation of CAS protein as a marker with a diagnostic potential.

Full text

PDF
25

Images in this article

27Figure 1
on p.27

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Brinkmann U., Brinkmann E., Gallo M., Pastan I. Cloning and characterization of a cellular apoptosis susceptibility gene, the human homologue to the yeast chromosome segregation gene CSE1. Proc Natl Acad Sci U S A. 1995 Oct 24;92(22):10427–10431. doi: 10.1073/pnas.92.22.10427. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Brinkmann U., Brinkmann E., Gallo M., Scherf U., Pastan I. Role of CAS, a human homologue to the yeast chromosome segregation gene CSE1, in toxin and tumor necrosis factor mediated apoptosis. Biochemistry. 1996 May 28;35(21):6891–6899. doi: 10.1021/bi952829+. [DOI] [PubMed] [Google Scholar]
  3. Brinkmann U., Brinkmann E., Pastan I. Expression cloning of cDNAs that render cancer cells resistant to Pseudomonas and diphtheria toxin and immunotoxins. Mol Med. 1995 Jan;1(2):206–216. [PMC free article] [PubMed] [Google Scholar]
  4. Brinkmann U., Gallo M., Polymeropoulos M. H., Pastan I. The human CAS (cellular apoptosis susceptibility) gene mapping on chromosome 20q13 is amplified in BT474 breast cancer cells and part of aberrant chromosomes in breast and colon cancer cell lines. Genome Res. 1996 Mar;6(3):187–194. doi: 10.1101/gr.6.3.187. [DOI] [PubMed] [Google Scholar]
  5. Dalla-Favera R., Lombardi L., Pelicci P. G., Lanfrancone L., Cesarman E., Neri A. Mechanism of activation and biological role of the c-myc oncogene in B-cell lymphomagenesis. Ann N Y Acad Sci. 1987;511:207–218. doi: 10.1111/j.1749-6632.1987.tb36249.x. [DOI] [PubMed] [Google Scholar]
  6. Harris N. L., Jaffe E. S., Stein H., Banks P. M., Chan J. K., Cleary M. L., Delsol G., De Wolf-Peeters C., Falini B., Gatter K. C. A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood. 1994 Sep 1;84(5):1361–1392. [PubMed] [Google Scholar]
  7. Lombardi L., Newcomb E. W., Dalla-Favera R. Pathogenesis of Burkitt lymphoma: expression of an activated c-myc oncogene causes the tumorigenic conversion of EBV-infected human B lymphoblasts. Cell. 1987 Apr 24;49(2):161–170. doi: 10.1016/0092-8674(87)90556-3. [DOI] [PubMed] [Google Scholar]
  8. Marin M. C., Hsu B., Meyn R. E., Donehower L. A., el-Naggar A. K., McDonnell T. J. Evidence that p53 and bcl-2 are regulators of a common cell death pathway important for in vivo lymphomagenesis. Oncogene. 1994 Nov;9(11):3107–3112. [PubMed] [Google Scholar]
  9. Marin M. C., Hsu B., Stephens L. C., Brisbay S., McDonnell T. J. The functional basis of c-myc and bcl-2 complementation during multistep lymphomagenesis in vivo. Exp Cell Res. 1995 Apr;217(2):240–247. doi: 10.1006/excr.1995.1083. [DOI] [PubMed] [Google Scholar]
  10. Scherf U., Pastan I., Willingham M. C., Brinkmann U. The human CAS protein which is homologous to the CSE1 yeast chromosome segregation gene product is associated with microtubules and mitotic spindle. Proc Natl Acad Sci U S A. 1996 Apr 2;93(7):2670–2674. doi: 10.1073/pnas.93.7.2670. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Tsujimoto Y., Cossman J., Jaffe E., Croce C. M. Involvement of the bcl-2 gene in human follicular lymphoma. Science. 1985 Jun 21;228(4706):1440–1443. doi: 10.1126/science.3874430. [DOI] [PubMed] [Google Scholar]
  12. Weiss L. M., Strickler J. G., Medeiros L. J., Gerdes J., Stein H., Warnke R. A. Proliferative rates of non-Hodgkin's lymphomas as assessed by Ki-67 antibody. Hum Pathol. 1987 Nov;18(11):1155–1159. doi: 10.1016/s0046-8177(87)80384-2. [DOI] [PubMed] [Google Scholar]

Articles from The American Journal of Pathology are provided here courtesy of American Society for Investigative Pathology

RESOURCES